Sex-specific impact on disease outcome and the mutational landscape in essential thrombocythemia: A retrospective cohort study-Reference-Cited by-同舟云学术

Sex-specific impact on disease outcome and the mutational landscape in essential thrombocythemia: A retrospective cohort study

Published:2024-04-15 Issue:12 Volume:137 Page:1495-1497
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Chen Jia¹²,Dong Huan¹²,Li Yang¹²,Sun Ting¹²,Fu Rongfeng¹²,Liu Xiaofan¹²,Xue Feng¹²,Liu Wei¹²,Chen Yunfei¹²,Ju Mankai¹²,Dai Xinyue¹²,Chi Ying¹²,Wang Wentian¹²,Li Huiyuan¹²,Yang Renchi¹²,Zhang Lei¹²³

Affiliation:

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin 300020, China

2. Tianjin Institutes of Health Science, Tianjin 301600, China

3. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera;Tefferi;Br J Haematol,2020

2. Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients;Tefferi;Am J Hematol,2017

3. Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden;Karantanos;Blood Adv,2020

4. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL International Working Group;Geyer;Haematologica,2017

5. Machine learning analyses constructed a novel model to predict recurrent thrombosis in adults with essential thrombocythemia;Chen;J Thromb Thrombolysis,2023